Journals / Diagnostic and Interventional Radiology / 2018 / Cilt: 24 - Sayı: 3

Treatment of femoro-popliteal lesions with scoring and drug-coated balloon angioplasty: 12-month results of the DCB-Trak registry

Pages
153–157
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Özet

-

🔖

Cite This Article

Baumhäkel, M., CHKHETİA, S., KİNDERMANN, M. (2018). Treatment of femoro-popliteal lesions with scoring and drug-coated balloon angioplasty: 12-month results of the DCB-Trak registry. Diagnostic and Interventional Radiology, Cilt: 24 - Sayı: 3, 153–157. https://ajindex.com/articles/173334

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Cunnane EM, Barrett HE, Kavanagh EG, Mongrain R, Walsh MT. The influence of composition and location on the toughness of human atherosclerotic femoral plaque tissue. Acta Biomater 2016
  2. 264–275. [CrossRef] Cotroneo AR, Pascali D, Iezzi R. Cutting balloon versus conventional balloon angioplasty in short femoropopliteal arterial stenoses. J Endovasc Ther 2008
  3. 283–291. [CrossRef] Tepe G, Beschorner U, Ruether C, et al. Drug-eluting balloon therapy for femoropopliteal occlusive disease: predictors of outcome with a special emphasis on calcium. J Endovasc Ther 2015
  4. 727–733. [CrossRef] Tellez A, Dattilo R, Mustapha JA, et al. Biological effect of orbital atherectomy and adjunctive paclitaxel-coated balloon therapy on vascular healing and drug retention: early experimental insights into the familial hypercholesterolaemic swine model of femoral artery stenosis. EuroIntervention 2014
  5. 1002–1008. [CrossRef] Cioppa A, Stabile E, Popusoi G, et al. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results. Cardiovasc Revasc Med 2012
  6. 219–223. [CrossRef] Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005
  7. 312–315. [CrossRef] Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv 2014
  8. E212–220. [CrossRef] Dattilo R, Himmelstein SI, Cuff RF. The COMPLIANCE 360° Trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J Invasive Cardiol 2014
  9. 355–360. Baumhäkel M, Chkhetia S, Kindermann M. Scoring- plus drug coated balloon in femoro-popliteal lesions - 6 months results of the DCB-Trak-Registry. J Cardiol and Ther 2016
  10. 8–12. [CrossRef] Poncyljusz W, Falkowski A, Safranow K, Rać M, Zawierucha D. Cutting-balloon angioplasty versus balloon angioplasty as treatment for short atherosclerotic lesions in the superficial femoral artery: randomized controlled trial. Cardiovasc Intervent Radiol 2013
  11. 1500–1507. [CrossRef] Fanelli F, Cannavale A, Gazzetti M, et al. Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Intervent Radiol 2014
  12. 898–907. [CrossRef] Micari A, Cioppa